# Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

> **NCT04054557** · NA · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 305 (actual)

## Conditions studied

- Stage 0 Breast Cancer AJCC v6 and v7
- Stage I Breast Cancer AJCC v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Stage IIIA Breast Cancer AJCC v7
- Stage IIIB Breast Cancer AJCC v7
- Stage IIIC Breast Cancer AJCC v7
- Stage III Breast Cancer AJCC v7

## Interventions

- **OTHER:** Telemedicine
- **OTHER:** Best Practice
- **OTHER:** Questionnaire Administration
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Survey Administration
- **BEHAVIORAL:** Behavioral Intervention
- **OTHER:** Educational Intervention

## Key facts

- **NCT ID:** NCT04054557
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-31
- **Primary completion:** 2024-12-06
- **Final completion:** 2024-12-06
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04054557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04054557, "Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04054557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*